Hamner, Mark B. M.D.; Labbate, Lawrence A. M.D.
CME article by Mark B. Hamner, M.D., Associate Professor, and Lawrence A. Labbate, M.D., Associate Professor, Medical University of South Carolina and VA Medical Center, Charleston, SC
Dr. Hamner has disclosed that he receives grant/research support from Bristol-Myers Squibb, Otsuka, Janssen, Wyeth-Ayerst, and Eli Lilly; and that he is a consultant to and/or on the speakers' bureau of Abbott, AstraZeneca, Janssen, Forest, and GlaxoSmithKline. Dr. Labbate has disclosed that he receives grant/research support from Eli Lilly and is on the speakers' bureau of Pfizer, Forest, and GlaxoSmithKline.
The authors also have disclosed that of the drugs discussed in this article, only sertraline and paroxetine have been approved by the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder.
